Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKesson
McKinsey
Boehringer Ingelheim
Medtronic
Colorcon
Express Scripts

Last Updated: October 21, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for MGL-3196

See Plans and Pricing

« Back to Dashboard

Drug Development Status for MGL-3196: Patents, clinical trial progress, indications

MGL-3196 is an investigational drug.

There have been 8 clinical trials for MGL-3196. The most recent clinical trial was a Phase 1 trial, which was initiated on September 15th 2017.

The most common disease conditions in clinical trials are Non-alcoholic Fatty Liver Disease, Fatty Liver, and Pain, Postoperative. The leading clinical trial sponsors are Madrigal Pharmaceuticals, Inc., Celerion, and Horizon Health Network.

There are five US patents protecting this investigational drug and seventy-eight international patents.

Recent Clinical Trials for MGL-3196
TitleSponsorPhase
A Phase 3 Study to Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and FibrosisMadrigal Pharmaceuticals, Inc.Phase 3
Bioavailability Study of MGL-3196 Tablets Compared to CapsulesCelerionPhase 1
Bioavailability Study of MGL-3196 Tablets Compared to CapsulesMadrigal Pharmaceuticals, Inc.Phase 1

See all MGL-3196 clinical trials

Clinical Trial Summary for MGL-3196

Top disease conditions for MGL-3196
Top clinical trial sponsors for MGL-3196

See all MGL-3196 clinical trials

US Patents for MGL-3196

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
MGL-3196   Start Trial Thyroid hormone analogs Hoffmann-La Roche Inc. (Nutley, NJ)   Start Trial
MGL-3196   Start Trial Thyroid hormone analogs Hoffmann-La Roche Inc. (Nutley, NJ)   Start Trial
MGL-3196   Start Trial Prodrugs of thyroid hormone analogs Hoffmann-La Roche Inc. (Nutley, NJ)   Start Trial
MGL-3196   Start Trial Method of synthesizing thyroid hormone analogs and polymorphs thereof Madrigal Pharmaceuticals, Inc. (Fort Washington, PA) Hoffmann-La Roche Inc. (Nutley, NJ)   Start Trial
MGL-3196   Start Trial Method of synthesizing thyroid hormone analogs and polymorphs thereof Madrigal Pharmaceuticals, Inc. (West Conshohocken, PA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for MGL-3196

Drugname Country Document Number Estimated Expiration Related US Patent
MGL-3196 Argentina 054848 2025-07-21   Start Trial
MGL-3196 Austria 480524 2025-07-21   Start Trial
MGL-3196 Australia 2006271721 2025-07-21   Start Trial
MGL-3196 Brazil PI0613754 2025-07-21   Start Trial
MGL-3196 Canada 2614529 2025-07-21   Start Trial
MGL-3196 China 101228135 2025-07-21   Start Trial
MGL-3196 Costa Rica 9644 2025-07-21   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Dow
AstraZeneca
Express Scripts
Medtronic
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.